Renoable Tablet

Introduction

Renoable, containing the active ingredient Alpha Ketoanalogue, is a prescription medication that is commonly used for the treatment of certain kidney disorders. It is available under the brand name Renoable.

Uses

Renoable is primarily prescribed to manage and slow down the progression of chronic kidney disease (CKD) in patients who are undergoing dialysis. It helps to control the levels of certain substances in the blood, such as urea and creatinine, which can accumulate when the kidneys are not functioning properly.

Dosage and Administration

The dosage of Renoable may vary depending on the individual patient’s condition and response to treatment. Follow the instructions provided by your healthcare provider. Generally, the recommended starting dose is one tablet taken three times a day with meals. Your doctor may adjust the dosage based on your specific needs.

Renoable is meant to be taken orally with water. Swallow the tablet whole, without crushing or chewing it, to ensure proper absorption of the medication.

Mechanism of Action

Renoable contains Alpha Ketoanalogue, which is a synthetic form of essential amino acids. These amino acids are important building blocks for proteins in the body. In patients with chronic kidney disease, the kidneys may not be able to adequately remove waste products from the blood. Alpha Ketoanalogue helps to supplement the levels of essential amino acids, which can be beneficial in managing the metabolic imbalances associated with kidney dysfunction.

Side Effects

Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. These side effects are usually mild and tend to resolve on their own. However, if they persist or worsen. Inform your healthcare provider.

In some rare cases, serious side effects can occur. These may include allergic reactions, such as rash, itching, or swelling, as well as difficulty breathing or chest pain. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Renoable may interact with certain medications, including certain antibiotics, antifungal medications, and medications used to treat high blood pressure. Inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential drug interactions.

Precautions

Before taking Renoable, inform your healthcare provider about any existing medical conditions, including allergies, liver disease, or a history of kidney stones. This medication may not be suitable for everyone, and your doctor will consider these factors when prescribing the medication.

Renoable is not recommended for use in pregnant or breastfeeding women without the explicit recommendation of a healthcare professional.

Storage

Renoable should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of the reach of children and pets. Do not use the medication if it has expired or if the packaging appears to be damaged.

Patient Tips

• Take Renoable exactly as prescribed by your healthcare provider. Do not alter the dosage or stop taking the medication without consulting your doctor.
• attend regular follow-up appointments with your healthcare provider to monitor your progress and make any necessary adjustments to your treatment plan.
• Stay well-hydrated by drinking an adequate amount of fluids, unless otherwise advised by your doctor.
• If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
• If you have any questions or concerns about Renoable, speak with your healthcare provider for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mastocytosis – Treatment (NHS UK) [Accessed 7 Jun. 2024] (online) Available at:
• Leibowitz J, Thoene J, Spector E, Nyhan W. Citrullinemia. Virchows Arch A Pathol Anat Histol. 1978 Mar 10;377(3):249-58. doi: 10.1007/BF00426934. [Accessed 0 Jun. 2024] Available at:
• Common questions about clonidine (NHS UK) [Accessed 5 Jun. 2024] (online) Available at:
• François G, Calderon A, Rose F, Blanc M, Lena P. [Inhibition of postoperative muscular proteolysis by sodium alpha-ketoisocaproate: does a dose-effect relation exist?]. Ann Fr Anesth Reanim. 1985;4(4):351-4. doi: 10.1016/s0750-7658(85)80104-0. [Accessed 5 Jun. 2024] Available at: